These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17975794)

  • 21. Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs.
    Ribas J; Boix J
    Exp Cell Res; 2004 Apr; 295(1):9-24. PubMed ID: 15051486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cyclin-dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker.
    Krucher NA; Meijer L; Roberts MH
    Cell Mol Neurobiol; 1997 Oct; 17(5):495-507. PubMed ID: 9353591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs.
    Ribas J; Gomez-Arbones X; Boix J
    Eur J Pharmacol; 2005 Nov; 524(1-3):49-52. PubMed ID: 16243312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early inhibition of DNA synthesis in the developing rat cerebral cortex by the purine analogues olomoucine and roscovitine.
    Yakisich JS; Sidén A; Idoyaga Vargas V; Eneroth P; Cruz M
    Biochem Biophys Res Commun; 1998 Feb; 243(3):674-7. PubMed ID: 9500988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roscovitine inhibits the proliferative activity of immortal and neoplastic human breast epithelial cells.
    Mgbonyebi OP; Russo J; Russo IH
    Anticancer Res; 1998; 18(2A):751-5. PubMed ID: 9615715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine.
    Schulze-Gahmen U; Brandsen J; Jones HD; Morgan DO; Meijer L; Vesely J; Kim SH
    Proteins; 1995 Aug; 22(4):378-91. PubMed ID: 7479711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia.
    Sankrithi N; Eskin A
    J Neurochem; 1999 Feb; 72(2):605-13. PubMed ID: 9930732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
    Zhang M; Li J; Chakrabarty P; Bu B; Vincent I
    Am J Pathol; 2004 Sep; 165(3):843-53. PubMed ID: 15331409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
    Wesierska-Gadek J; Gueorguieva M; Horky M
    Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
    Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L
    Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells.
    Nuckolls FJ; Khan AS; Butler R; Katula KS
    Biochem Biophys Res Commun; 1998 Mar; 244(1):280-4. PubMed ID: 9514874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
    Moreau JL; Marques F; Barakat A; Schatt P; Lozano JC; Peaucellier G; Picard A; Genevière AM
    Dev Biol; 1998 Aug; 200(2):182-97. PubMed ID: 9705226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein.
    Ratner N; Bloom GS; Brady ST
    J Neurosci; 1998 Oct; 18(19):7717-26. PubMed ID: 9742142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of cyclin dependent protein kinase inhibitor olomoucine on the neuronal apoptosis after status epilepticus: experiment with rats].
    Du XP; Sun MZ; Yu ZY; Chen HX; Tian DS; Xie MJ; Wang W
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2025-9. PubMed ID: 17925171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDK inhibitors suppress apoptosis induced by chemicals and by excessive expression of a cell death gene, reaper, in Drosophila cells.
    Nagano M; Ui-Tei K; Suzuki H; Piao Z; Miyata Y
    Apoptosis; 2000 Dec; 5(6):543-50. PubMed ID: 11303913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin-dependent kinase (CDK) inhibitor olomoucine enhances gamma-irradiation-induced apoptosis and cell cycle arrest in Raji cells.
    Boutis A; Papazisis K; Pistevou-Gompaki K; Lambropoulos A; Sofroniadis I; Papageorgiou A; Destouni E; Kortsaris A
    Anticancer Res; 2006; 26(5A):3493-8. PubMed ID: 17094472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons.
    Appert-Collin A; Hugel B; Levy R; Niederhoffer N; Coupin G; Lombard Y; André P; Poindron P; Gies JP
    Life Sci; 2006 Jun; 79(5):484-90. PubMed ID: 16530228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
    Wesierska-Gadek J; Kramer MP; Maurer M
    Food Chem Toxicol; 2008 Apr; 46(4):1327-33. PubMed ID: 17933449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
    Havlícek L; Hanus J; Veselý J; Leclerc S; Meijer L; Shaw G; Strnad M
    J Med Chem; 1997 Feb; 40(4):408-12. PubMed ID: 9046330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M; Tani K; Asano S
    Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.